Haisco Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 96.3% in First Three Quarters of 2023

Haisco Pharmaceutical Group Co.,Ltd. (海思科医药集团股份有限公司) (002653.SZ) reported a net profit of 201.2 million yuan in the first three quarters of 2023, up 96.3% year-on-year.

Meanwhile, the company posted 2.4 billion yuan in revenue, up 13.7% year-on-year.

At the end of the reporting period, it had 6.2 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 34.3%.